Pamidronate Reduces PTH-mediated bone loss in a gene transfer model of hyperparathyroidism in rats
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo
1969 • 758 citations
Skeletal disease in primary hyperparathyroidism
1989 • 616 citations
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
1991 • 375 citations
Clinical Disorders of Bone and Mineral Metabolism
1983 • 307 citations
Quantitative Digital RadiographyVersusDual Photon Absorptiometry of the Lumbar Spine*
1988 • 216 citations
Effects of Dichloromethylene Diphosphonate on Serum and Urinary Calcium in Primary Hyperparathyroidism
1981 • 93 citations
Experimental Hyperparathyroidism from Multiple Isologous Parathyroid Transplants: Homeostatic Effect of Simultaneous Thyroid Transplants11
1966 • 72 citations
Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate
1982 • 48 citations
Ability of different techniques of measuring bone mass to determine vertebral bone loss in aging female rats
1988 • 37 citations
Bone mineral analysis of the rat femur by direct photon absorptiometry
1981 • 32 citations
Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry
1990 • 17 citations
AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE TREATMENT OF HYPERCALCEMIC CRISIS DUE TO PRIMARY HYPERPARATHYROIDISM
1987 • 17 citations
Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate
1981 • 11 citations